Skip to main content

Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.